The Role of the Tumor Molecular Profile (CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of the Intestinal Microbiota for Treatment Efficiency, Toxicity, Survival and Quality of Life in Patients With Metastatic or Unresectable Colorectal Cancer During Irinotecan-based Systemic Treatment
Clinical trial NCT05655780 · RECRUITING
Trial details
- NCT number
- NCT05655780
- Sponsor
- Maastricht University Medical Center
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-09
- Primary completion
- 2025-10-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.